List view / Grid view
20 April 2016 | By Victoria White, Digital Content Producer
Enterome Bioscience has raised €14.5 million in a Series C financing round that it will use to advance the development of its lead drug candidate EB 8018...
19 April 2016 | By Victoria White, Digital Content Producer
Enterome has signed a license agreement with Vertex to research, develop and commercialise novel small molecule FimH antagonists...
7 January 2016 | By Nicholas Jackson
Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease...
6 January 2016 | By Victoria White
As part of the collaboration, Enterome will use its metagenomic platform to support the discovery of potential novel agents derived from gut bacteria and directed to gastrointestinal targets...
12 November 2015 | By Victoria White
The collaboration’s ambitious objective is to develop a new generation of drugs and non-invasive monitoring tools of the gut microbiome in immuno-oncology...
